SCHEMBL19503779

SCHEMBL19503779

CC(C)(S)c1cccc(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
MAPK1 P28482 1/20 0.50
HTR3E A5X5Y0 1/20 0.46
HTR3B O95264 1/20 0.46
HTR3A P46098 1/20 0.46
HTR3D Q70Z44 1/20 0.46
HTR3C Q8WXA8 1/20 0.46
CES2 O00748 1/20 0.45
MGLL Q99685 1/20 0.45
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
HTR2B P41595 1/20 0.44
ALDH1A1 P00352 1/20 0.44
NFE2L2 Q16236 1/20 0.43
TAAR1 Q96RJ0 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
IDO1 P14902 2/20 0.41
IDH2 P48735 1/20 0.41
RAPGEF4 Q8WZA2 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL62723 0.83 TSHR (0.67) TSHRMAPK1HTR3EHTR3BHTR3A
SCHEMBL22019286 0.81 HDAC8 (0.47) TSHRALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL178282 0.81 TSHR (0.54) TSHRMAPK1HTR3EHTR3BHTR3A
SCHEMBL14030559 0.81 TSHR (0.54) TSHRMAPK1HTR3EHTR3BHTR3A
Methylamine SCHEMBL27581718 0.80 TSHR (0.65) TSHRMAPK1HTR3EHTR3BHTR3A
Methyl Alcohol SCHEMBL9419583 0.80 TSHR (0.58) TSHRMAPK1HTR3EHTR3BHTR3A
Fluoride SCHEMBL30661872 0.80 TSHR (0.64) TSHRMAPK1HTR3EHTR3BHTR3A
SCHEMBL30553105 0.80 TSHR (0.64) TSHRMAPK1HTR3EHTR3BHTR3A
Benzene SCHEMBL8568955 0.80 TSHR (0.67) TSHRMAPK1HTR3EHTR3BHTR3A
SCHEMBL30252943 0.80 TSHR (0.64) TSHRMAPK1HTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3661921-B1 SELECTIVE INHIBITORS OF NLRP3 INFLAMMASOME NODTHERA LTD (GB) 2023-10-18 EP disclosed
US-20170305902-A1 TETRAHYDRONAPHTHYRIDINE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2017-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170305902-A1 TETRAHYDRONAPHTHYRIDINE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE GRIN2A, GRIN2C, GRIN2B TSHR 859/4885MAPK1 2191/4885HTR3E 122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.